Natco extends gains on US court ruling over generic Copaxone
Shares of Natco Pharma extended gains for the third straight session rising 10% after a US Supreme Court ruling paved the way for the company to launch the generic version of Teva's Copaxone.
RIL inches up after tying up ECA facility
Reliance Industries rose 0.36% after the company has signed loan co-financed by JBIC and Japanese banks backed by Nippon Export and Investment Insurance for up to $550 million.
YES Bank Q4 profit jumps 18% to Rs 430 cr, NPA improves
YES Bank reporting fourth quarter net profit at Rs 430 crore, up 18.8 percent compared to same quarter last year, driven by non-interest income. Net interest income grew 12.8 percent to Rs 719.6 crore on account of a cautious and steady growth in advances during the quarter while other income climbed 17.4 percent to Rs 445.52 crore year-on-year.
Muthoot Finance dips on discounted price for share sale
Muthoot Finance has dipped 4% after the company fixed price band of Rs 155-165 per share for its proposed share sale, which is at a discount to the prevailing share price.
Shares of Natco Pharma extended gains for the third straight session rising 10% after a US Supreme Court ruling paved the way for the company to launch the generic version of Teva's Copaxone.
RIL inches up after tying up ECA facility
Reliance Industries rose 0.36% after the company has signed loan co-financed by JBIC and Japanese banks backed by Nippon Export and Investment Insurance for up to $550 million.
YES Bank Q4 profit jumps 18% to Rs 430 cr, NPA improves
YES Bank reporting fourth quarter net profit at Rs 430 crore, up 18.8 percent compared to same quarter last year, driven by non-interest income. Net interest income grew 12.8 percent to Rs 719.6 crore on account of a cautious and steady growth in advances during the quarter while other income climbed 17.4 percent to Rs 445.52 crore year-on-year.
Muthoot Finance dips on discounted price for share sale
Muthoot Finance has dipped 4% after the company fixed price band of Rs 155-165 per share for its proposed share sale, which is at a discount to the prevailing share price.
For More Detail Call Us 0731-6790000,6669900
Click Here capitalstars.com
Click Here capitalstars.com
0 Comments